Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Complex antibody profiling to predict clinical outcome in childhood ADS.
Alemtuzumab benefits hard-to-treat MS patients
Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Chronic cladribine administration increases amyloid Beta Peptide generation and plaque burden in mice.
Development of cladribine at Scripps for hairy cell leukemia and current results.
Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
Multiple sclerosis: risk factors, prodromes, and potential causal pathways.
Genmab announces results of ofatumumab Phase II study in multiple sclerosis
GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach to Treat Multiple Sclerosis: Patients Receiving First in Class GNbAC1 Mab Are Stable After One Year
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases.
A G protein-coupled receptor is essential for Schwann cells to initiate myelination.
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Inflammatory cortical demyelination in early multiple sclerosis.
The immunopathology of multiple sclerosis: an overview.
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
Trimesta in relapsing-remitting multiple sclerosis patients (Phase II)
Intas launches biosimilar version of Rituximab
A novel pH-sensitive interferon-β (INF-β) oral delivery system for application in multiple sclerosis.

Pages